🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double blind, randomized, parallel group design placebo-controlle...
Status
Completed
Location
UCSF MS Center , 675 Nelson Rising Lane, Suite 221
Start Date
2006-07
Trial ID
NCT00501943
Treatments Being Tested
When people with asthma get respiratory virus such as a cold or flu it ofte...
Status
Completed
Location
Southampton University General Hospital
Start Date
2010-03
Trial ID
NCT01126177
Treatments Being Tested
The primary objective of the study is to determine whether titration of Avo...
Status
Completed
Location
Research Site
Start Date
2010-05-05
Trial ID
NCT01119677
Treatments Being Tested
Some of the most common side effects of the multiple sclerosis drug Plegrid...
Status
Unknown
Location
Holy Name Medical Center
Start Date
2017-09-25
Trial ID
NCT03424733
Treatments Being Tested
This is a randomized double-blind crossover study of pharmacokinetics, phar...
Status
Completed
Location
City Mariin Hospital
Start Date
2013-02
Trial ID
NCT01766024
Treatments Being Tested
The primary objective of the study is to evaluate safety and tolerability a...
Status
Completed
Location
Hospital Fernando Fonseca
Start Date
2017-01-30
Trial ID
NCT03177083
Treatments Being Tested
General Note: throughout this record, "Rebif® New Formulation" is used for ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00441103
Treatments Being Tested
A randomized, double-blind, clinical trial to assess the safety and efficac...
Status
Completed
Location
Hope Research Institute Medical Plaza LLC Desert Hills
Start Date
2008-12-31
Trial ID
NCT00725985
Treatments Being Tested
The primary objective of the study is to evaluate the pharmacokinetics (PK)...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01119781
Treatments Being Tested
Phase I study aiming at: * assessing the absolute bioavailability, pharmac...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT02515695
Treatments Being Tested